Literature DB >> 2622329

Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen.

N Guiso1, M Rocancourt, M Szatanik, J M Alonso.   

Abstract

Bordetella pertussis and Bordetella parapertussis are both causative agents of whooping cough outbreaks. Although not expressing the pertussis toxin, B. parapertussis induces, in a murine model, an acute hemorrhagic edematous alveolitis, similar to that observed with B. pertussis. These data suggest that the pertussis toxin may only play an accessory role in the acute pulmonary syndrome observed during Bordetella infection. Both with B. pertussis and B. parapertussis, the ability to induce lethal pulmonary lesions is associated with enhanced in vitro adenylate cyclase expression and activity. We also demonstrate that passive immunization with specific anti-B. pertussis adenylate cyclase antibodies or active immunization with purified B. pertussis secreted adenylate cyclase protect mice against a lethal respiratory challenge with B. pertussis or B. parapertussis. Our results suggest that adenylate cyclase might be the primary cytotoxin responsible for mouse pulmonary lesions during respiratory tract infection with B. pertussis or with the related species B. parapertussis and is a protective antigen of B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2622329     DOI: 10.1016/0882-4010(89)90040-5

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  22 in total

1.  Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.

Authors:  L Bassinet; P Gueirard; B Maitre; B Housset; P Gounon; N Guiso
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Mylisa R Parette; Sara E Hester; Julian Parkhill; Eric T Harvill
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

4.  Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry.

Authors:  M C Gray; W Ross; K Kim; E L Hewlett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.

Authors:  M K Gross; D C Au; A L Smith; D R Storm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 6.  Pertussis pathogenesis--what we know and what we don't know.

Authors:  Erik L Hewlett; Drusilla L Burns; Peggy A Cotter; Eric T Harvill; Tod J Merkel; Conrad P Quinn; E Scott Stibitz
Journal:  J Infect Dis       Date:  2014-04-01       Impact factor: 5.226

7.  Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.

Authors:  N Khelef; C M Bachelet; B B Vargaftig; N Guiso
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Effect of methyl-cyclodextrin on adenylate cyclase activity of Bordetella pertussis.

Authors:  D F Hozbor; A Samo; O M Yantorno
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.